BK Medical - 2023 Major Industry Partner

Our mission at BK is to change the standard of care in surgical interventions with real-time visual guidance, giving surgeons the information needed to immediately make critical decisions.

As a leader in surgical visualization and guidance, BK Medical provides Active Imaging and real-time visual evidence when it matters most — during surgery. Our compact, easy-to-use systems seamlessly integrate into any OR setting complemented by imaging architecture and sterilizable within-body transducers designed for organ-specific tissue differentiation. With our real-time visualisation and guidance platform, we empower surgeons when it matters most: during the procedure.

Now, BK Medical is advancing its mission with GE Healthcare. Together, we will reach more customers and continue to empower surgeons to make critical decisions that allow for better care, faster procedures, and reduced complications.

Medtronic - 2023 Major Industry Partner

Bold thinking. Bolder actions. We are Medtronic.

We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.

In everything we do, we are engineering the extraordinary.

Sirtex - 2023 Industry Partner

Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve the quality and longevity of patients’ lives by providing innovative interventional oncology solutions. Our product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. Over 125,000 doses have been supplied to treat patients with liver cancer at more than 1,400 medical centers worldwide. SIR-Spheres® Y-90 resin microspheres target liver tumors with radiation via the hepatic artery during minimally invasive Selective Internal Radiation Therapy (SIRT). For more information, visit www.sirtex.com and connect with us on LinkedIn and Twitter.